VenatoRx reports preclinical data for VNRX-5133 plus cefepime

VenatoRx Pharmaceuticals Inc. (Malvern, Pa.) reported preclinical data from

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE